Close

ERBA Diagnostics (ERB) Will Begin Trading OTC Under 'ERBA'

Go back to ERBA Diagnostics (ERB) Will Begin Trading OTC Under 'ERBA'

ERBA Diagnostics to Commence Trading on OTC Markets’ Pink Open Market After Delisting by the NYSE MKT

September 30, 2016 4:00 PM EDT

MIAMI, Sept. 30, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (the Company), a fully integrated in vitro diagnostics company, previously disclosed that the Company expected the NYSE MKT LLC (the Exchange) to initiate procedures to delist the Companys common stock, including the issuance of a delisting notice to the Company, and that the Company planned to disclose receipt of such notice.  At market-close on September 29, 2016, the Exchange suspended trading in the Companys common stock.  On September 30, 2016, the Company received the delisting notice from the Exchange stating that the Exchange has determined to commence proceedings to delist the Companys common... More

ERBA Diagnostics, Inc. Announces Inability to Meet Deadline to Regain Compliance With NYSE MKT Continued Listing Standards

September 29, 2016 4:05 PM EDT

MIAMI, Sept. 29, 2016 (GLOBE NEWSWIRE) -- As previously reported, ERBA Diagnostics, Inc. (NYSE MKT: ERB) (the Company), a fully integrated in vitro diagnostics company, implemented during the third quarter of 2015, among other things, a new, enhanced balance sheet review process, with a particular focus on reconciliation of significant accounts, including, among others, intercompany accounts, and corresponding eliminations made, or required to be made, at the consolidated level, and their potential impact on the Companys consolidated financial statements. As previously... More